Related Experiment Video
Updated: Aug 8, 2026

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
Published on: October 31, 2010
Principles of selecting cost-effectiveness thresholds in price-taker countries
Zoltán Kaló1,2,3, Maureen Rutten-van Mölken4,5,6, Eline Aas7,8
1Center for Health Technology Assessment, Semmelweis University, Budapest, Hungary.
Price-taker countries need well-defined cost-effectiveness thresholds (CETs) to evaluate new medicines. This paper guides establishing and updating these crucial economic assessment tools for pharmaceutical value.
Area of Science:
- Health Economics
- Pharmaceutical Policy
- Health Technology Assessment
Background:
- Small market countries act as price-takers, lacking pharmaceutical pricing power.
- Cost-effectiveness thresholds (CETs) are vital for assessing new medicine value in these nations.
Purpose of the Study:
- To provide an overview of establishing or reconsidering CETs in pharmaceutical price-taker countries.
- To detail key aspects of selecting and applying CETs in policy decisions.
Main Methods:
- Review of methodologies for establishing baseline CETs.
- Analysis of factors influencing CET modification for justified higher spending.
- Examination of the policy decision-making process involving CETs.
Main Results:
- Many academic CET approaches lack practical implementation.
- Upcoming years will see several price-taker countries introducing or updating CETs.
- Economic growth may lead lower-income countries to reduce CETs, while higher-income nations face pressure to increase them.
Conclusions:
- Effective CETs are essential for pharmaceutical market access in price-taker countries.
- Policy decisions regarding CETs require careful consideration of economic factors and growth.
- Future adjustments in CETs will reflect economic realities and inflation.
Related Concept Videos
Decision Making: Traditional Method
First, a specific claim about the population parameter is decided based on the research question and is stated in a simple form. Further, an opposing statement to this claim is also stated. These statements can act as null and alternative hypotheses, out of which a null hypothesis would be a...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Decision Making: P-value Method
First, a specific claim about the population parameter is proposed. The claim is based on the research question and is stated in a simple form. Further, an opposing statement to the claim is also stated. These statements can act as null and alternative hypotheses: a null hypothesis would be a neutral statement while the alternative hypothesis can have a...
Methods of Medium Optimization
The Anchoring-and-Adjustment Heuristic
